Amgen, Takeda's Cancer Drug Test Stopped After Deaths (Update1) - Bloomberg

TheMedGuru

Amgen, Takeda's Cancer Drug Test Stopped After Deaths (Update1) Bloomberg - 21 hours ago Motesanib was being used in a late-stage test as an initial treatment with chemotherapy for non-small cell lung cancer, the most common form of the disease, ... Amgen, Takeda suspend drug for Lung Cancer following negative results TheMedGuru No heart risk seen with Takeda gout drug: FDA Reuters all 56 news articles

Antisoma AGM update and Interim Management Statement - FOXBusiness

Antisoma AGM update and Interim Management Statement FOXBusiness - Nov 18, 2008 A 1200-patient phase III trial (ATTRACT-1) is testing the drug as a first-line treatment for non-small cell lung cancer. This is the setting in which we ...

In Depth Interview: Lung Cancer Vaccine - WCTV

In Depth Interview: Lung Cancer Vaccine WCTV, FL - Nov 13, 2008 If you are diagnosed with lung cancer in the early stage, then the survival is certainly better, but the chances of you being diagnosed in early stages are ...

ArQule Makes Two Deals with Daiichi in Cancer - BioWorld Online

ArQule Makes Two Deals with Daiichi in Cancer BioWorld Online, GA - Nov 10, 2008 He said the compound, a c-Met inhibitor, currently is in Phase II studies for pediatric sarcoma, lung cancer and pancreatic cancer, with interim data in ... ArQule, Inc. Q3 2008 Earnings Call Transcript Seeking Alpha all 38 news articles

OXiGENE Reports Positive Phase 2 Interim Results in Platinum ... - MarketWatch

OXiGENE Reports Positive Phase 2 Interim Results in Platinum ... MarketWatch - Oct 26, 2008 Phase II studies in platinum-resistant ovarian cancer and non-small cell lung cancer are also ongoing. OXiGENE believes that ZYBRESTAT is poised to become ...